Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease

被引:626
作者
Slow, EJ
van Raamsdonk, J
Rogers, D
Coleman, SH
Graham, RK
Deng, Y
Oh, R
Bissada, N
Hossain, SM
Yang, YZ
Li, XJ
Simpson, EM
Gutekunst, CA
Leavitt, BR
Hayden, MR
机构
[1] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada
[2] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
基金
加拿大健康研究院; 加拿大创新基金会; 美国国家科学基金会;
关键词
D O I
10.1093/hmg/ddg169
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An expanded CAG repeat is the underlying genetic defect in Huntington disease, a disorder characterized by motor, psychiatric and cognitive deficits and striatal atrophy associated with neuronal loss. An accurate animal model of this disease is crucial for elucidation of the underlying natural history of the illness and also for testing experimental therapeutics. We established a new yeast artificial chromosome (YAC) mouse model of HD with the entire human HD gene containing 128 CAG repeats (YAC128) which develops motor abnormalities and age-dependent brain atrophy including cortical and striatal atrophy associated with striatal neuronal loss. YAC128 mice exhibit initial hyperactivity, followed by the onset of a motor deficit and finally hypokinesis. The motor deficit in the YAC128 mice is highly correlated with striatal neuronal loss, providing a structural correlate for the behavioral changes. The natural history of HD-related changes in the YAC128 mice has been defined, demonstrating the presence of huntingtin inclusions after the onset of behavior and neuropathological changes. The HD-related phenotypes of the YAC128 mice show phenotypic uniformity with low inter-animal variability present, which together with the age-dependent striatal neurodegeneration make it an ideal mouse model for the assessment of neuroprotective and other therapeutic interventions.
引用
收藏
页码:1555 / 1567
页数:13
相关论文
共 49 条
[1]  
[Anonymous], 1991, HUNTINGTONS DIS
[2]  
Brinkman RR, 1997, AM J HUM GENET, V60, P1202
[3]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[4]   NMDA receptor function in mouse models of Huntington disease [J].
Cepeda, C ;
Ariano, MA ;
Calvert, CR ;
Flores-Hernández, J ;
Chandler, SH ;
Leavitt, BR ;
Hayden, MR ;
Levine, MS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) :525-539
[5]   LESION OF STRIATAL NEURONS WITH KAINIC ACID PROVIDES A MODEL FOR HUNTINGTONS-CHOREA [J].
COYLE, JT ;
SCHWARCZ, R .
NATURE, 1976, 263 (5574) :244-246
[6]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548
[7]   A SIMPLE, SINGLE-STEP TECHNIQUE FOR SELECTING AND CLONING HYBRIDOMAS FOR THE PRODUCTION OF MONOCLONAL-ANTIBODIES [J].
DAVIS, JM ;
PENNINGTON, JE ;
KUBLER, AM ;
CONSCIENCE, JF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 50 (02) :161-171
[8]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[9]   Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice [J].
Dragatsis, I ;
Levine, MS ;
Zeitlin, S .
NATURE GENETICS, 2000, 26 (03) :300-306
[10]  
DUFF K, 1994, GENE THER, V1, P70